To determine whether there is a connection between Smurf2 suppression and Topo IIα degradation, we knocked down SMURF2 gene expression with either siRNA or shRNA in EGFRm NSCLC cells and then examined Topo IIα alterations in these cell lines. The gene discussed is SMURF2; the disease is non-small cell lung carcinoma.